Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 25
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Llonga, Natalia|||0000-0003-4325-6201
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Carabí-Gassol, Pau
  • Arribas, Lorena|||0000-0002-9683-9999
  • Macias-Chimborazo, Valeria
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • del Castillo, Clara
  • Martínez, Laura
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Pagespetit, Èlia
  • Prat, Raquel|||0000-0001-8097-6617
  • Puigbó, Julia
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor

  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Harder, Aster|||0000-0002-5477-7232
  • Ran, Caroline
  • Chalmer, Mona A.
  • Dalmasso, Maria Carolina|||0000-0002-4901-9955
  • Ferkingstad, Egil
  • Tripathi, Kumar Parijat|||0000-0002-3998-599X
  • Bacchelli, Elena|||0000-0001-8800-9568
  • Børte, Sigrid|||0000-0001-9540-3256
  • Fourier, Carmen|||0000-0001-6618-8948
  • Petersen, Anja S.
  • Vijfhuizen, Lisanne S.
  • Magnusson, Sigurdur H.
  • O'Connor, Emer
  • Bjornsdottir, Gyda
  • Häppölä, Paavo
  • Wang, Yen-Feng|||0000-0001-7027-3432
  • Callesen, Ida
  • Kelderman, Tim
  • Gallardo López, Victor José|||0000-0002-3042-2007
  • de Boer, Irene|||0000-0002-7261-762X
  • Olofsgård, Felicia Jennysdotter
  • Heinze, Katja
  • Lund, Nunu
  • Thomas, Laurent|||0000-0003-0548-2486
  • Hsu, Chia-Lin
  • Pirinen, Matti|||0000-0002-1664-1350
  • Hautakangas, Heidi
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Guerzoni, Simona|||0000-0001-9589-2782
  • Sivakumar, Prasanth
  • Yip, Janice
  • Heinze, Axel
  • Küçükali, Fahri
  • Ostrowski, Sisse Rye|||0000-0001-5288-3851
  • Pedersen, Ole B.
  • Kristoffersen, Espen Saxhaug|||0000-0002-8999-5424
  • Martinsen, Amy E.|||0000-0002-9051-9898
  • Artigas, María S.
  • Lagrata, Susie|||0000-0002-5672-5540
  • Cainazzo, Maria Michela
  • Adebimpe, Joycee
  • Quinn, Olivia
  • Göbel, Carl
  • Cirkel, Anna
  • Volk, Alexander E.
  • Heilmann-Heimbach, Stefanie|||0000-0003-1057-465X
  • Skogholt, Anne Heidi|||0000-0001-7466-0405
  • Gabrielsen, Maiken E.
  • Wilbrink, Leopoldine A.
  • Danno, Daisuke
  • Mehta, Dwij
  • Guðbjartsson, Daníel F.
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Willems van Dijk, Ko
  • Fronczek, Rolf|||0000-0002-1935-7603
  • Wagner, Michael
  • Scherer, Martin
  • Göbel, Hartmut
  • Sleegers, Kristel|||0000-0002-0283-2332
  • Sveinsson, Olafur A.
  • Pani, Luca|||0000-0001-9273-2839
  • Zoli, Michele
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Dardiotis, Efthimios|||0000-0003-2957-641X
  • Steinberg, Anna
  • Riedel-Heller, Steffi|||0000-0003-4321-6090
  • Sjöstrand, Christina
  • Thorgeirsson, Thorgeir E.|||0000-0002-5149-7040
  • Stefánsson, Hreinn|||0000-0002-9331-6666
  • Southgate, Laura|||0000-0002-2090-1450
  • Trembath, Richard C.
  • Vandrovcova, Jana
  • Noordam, Raymond|||0000-0001-7801-809X
  • Paemeleire, Koen|||0000-0001-8103-3899
  • Stefánsson, Kári|||0000-0003-1676-864X
  • Fann, Cathy Shen-Jang
  • Waldenlind, Elisabet
  • Tronvik, Erling|||0000-0001-6059-0151
  • Højland Jensen, Rigmor
  • Chen, Shih-Pin|||0000-0003-3492-9902
  • Houlden, Henry|||0000-0002-2866-7777
  • Terwindt, Gisela|||0000-0003-3140-6882
  • Kubisch, Christian|||0000-0003-4220-0978
  • Maestrini, Elena|||0000-0001-5924-3179
  • Vikelis, Michail
  • Pozo-Rosich, Patricia|||0000-0003-0796-4702
  • Belin, Andrea C.|||0000-0001-6668-3172
  • Matharu, Manjit|||0000-0002-4960-2294
  • van den Maagdenberg, Arn M. J. M.|||0000-0002-9310-5535
  • Hansen, Thomas F.
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Zwart, John-Anker|||0000-0001-5721-0154
The objective of this study was to aggregate data for the first genomewide association study meta-analysis of cluster headache, to identify genetic risk variants, and gain biological insights. A total of 4,777 cases (3,348 men and 1,429 women) with clinically diagnosed cluster headache were recruited from 10 European and 1 East Asian cohorts. We first performed an inverse-variance genomewide association meta-analysis of 4,043 cases and 21,729 controls of European ancestry. In a secondary trans-ancestry meta-analysis, we included 734 cases and 9,846 controls of East Asian ancestry. Candidate causal genes were prioritized by 5 complementary methods: expression quantitative trait loci, transcriptome-wide association, fine-mapping of causal gene sets, genetically driven DNA methylation, and effects on protein structure. Gene set and tissue enrichment analyses, genetic correlation, genetic risk score analysis, and Mendelian randomization were part of the downstream analyses. The estimated single nucleotide polymorphism (SNP)-based heritability of cluster headache was 14.5%. We identified 9 independent signals in 7 genomewide significant loci in the primary meta-analysis, and one additional locus in the trans-ethnic meta-analysis. Five of the loci were previously known. The 20 genes prioritized as potentially causal for cluster headache showed enrichment to artery and brain tissue. Cluster headache was genetically correlated with cigarette smoking, risk-taking behavior, attention deficit hyperactivity disorder (ADHD), depression, and musculoskeletal pain. Mendelian randomization analysis indicated a causal effect of cigarette smoking intensity on cluster headache. Three of the identified loci were shared with migraine. This first genomewide association study meta-analysis gives clues to the biological basis of cluster headache and indicates that smoking is a causal risk factor. ANN NEUROL 2023;94:713-726.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations between air pollution and surrounding greenness with internalizing and externalizing behaviors among schoolchildren

  • Zubizarreta-Arruti, Uxue
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Carabí-Gassol, Pau
  • Macias-Chimborazo, Valeria
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Prat, Raquel|||0000-0001-8097-6617
  • Rivas, Cristina|||0000-0002-8074-9550
  • Pagespetit, Èlia
  • Puigbó, Júlia
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • Raimbault, B.|||0000-0003-0226-0220
  • Valentín, Antònia|||0000-0002-9275-7101
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Foraster, Maria|||0000-0003-4450-4123
  • Gascon, Mireia|||0000-0003-4537-8472
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
Air pollution and greenness are emerging as modifiable risk and protective factors, respectively, in child psychopathology. However, research shows inconsistencies. Here, we examined associations between air pollution and surrounding greenness with internalizing and externalizing behaviors. In addition, the potential modifying role of the genetic susceptibility for these traits and socioeconomic status (SES) was explored. This population-based study included 4485 schoolchildren aged 5-18 years from Spain. Internalizing and externalizing behaviors were assessed using the Child Behavior Checklist (CBCL). Average air pollution (NO, PM, PM, PM, and PM absorbance) and surrounding greenness (NDVI within 100-m, 300-m, and 500-m buffers) school exposure were estimated for 12 months before outcome assessment. Genetic liability was assessed by computing polygenic risk scores (PRS) and SES was calculated using the Hollingshead Four-Factor Index. Associations were analyzed using negative binomial mixed-effects models. Although no associations survived multiple testing, we found that increases of 5.48 μg/m 3 in PM and 2.93 μg/m 3 in PM were associated with a 6% (Mean Ratio (MR) = 1.06; 95% CI: 1.01-1.12) and a 4% (MR = 1.04; 95% CI: 1.00-1.09) increase in internalizing behavior scores. A 0.1 increase in NDVI within a 100-m buffer was associated with a 6% decrease in externalizing behavior (MR = 0.94; 95% CI: 0.89-0.99). Neither differences by sex or age, or moderation effects by PRS or SES, were observed. We found preliminary evidence of detrimental effects of air pollution on internalizing behavior and protective effects of greenness on externalizing behavior, which were not modified by sex, age, SES, or genetic liability. If confirmed, these results reinforce the need for improving air quality, especially around schools, as part of preventive strategies focused on childhood psychopathology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder

  • Strom, Nora I.|||0000-0002-5261-8852
  • Gerring, Zachary F.|||0000-0002-2445-1266
  • Galimberti, Marco|||0000-0001-6052-156X
  • Yu, Dongmei|||0000-0001-7901-4365
  • Halvorsen, Matthew W.|||0000-0002-6707-2418
  • Abdellaoui, Abdel|||0000-0003-1088-6784
  • Rodriguez-Fontenla, Cristina|||0000-0002-9829-6393
  • Sealock, Julia M.|||0000-0002-9346-3498
  • Bigdeli, Tim
  • Coleman, Jonathan R. I.|||0000-0002-6759-0944
  • Mahjani, Behrang|||0000-0001-6087-9537
  • Thorp, Jackson G.|||0000-0002-9461-6417
  • Bey, Katharina|||0000-0001-6392-4997
  • Burton, Christie L.|||0000-0002-8955-6528
  • Luykx, Jurjen J.|||0000-0002-6439-2774
  • Zai, Gwyneth|||0000-0002-0894-6867
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Andre, Christine
  • Askland, Kathleen D.|||0000-0003-1467-8923
  • Bäckman, Julia
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Barlassina, Cristina|||0000-0001-7407-2697
  • Nissen, Judith Becker|||0000-0003-4063-6866
  • Bienvenu, O. Joseph|||0000-0002-8466-102X
  • Black, Donald|||0000-0001-8038-1971
  • Bloch, Michael H.|||0000-0003-0352-4080
  • Børte, Sigrid|||0000-0001-9540-3256
  • Bosch, Rosa|||0000-0002-7596-183X
  • Breen, Michael
  • Brennan, Brian P.|||0000-0001-5468-6552
  • Brentani, Helena|||0000-0001-5192-4682
  • Buxbaum, Joseph D.|||0000-0001-8898-8313
  • Bybjerg-Grauholm, Jonas|||0000-0003-1705-4008
  • Byrne, Enda M.|||0000-0002-9491-7797
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Camarena, Beatriz
  • Camarena, Adrian|||0000-0001-8512-0607
  • Cappi, Carolina|||0000-0001-6661-3756
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Cavallini, Maria Cristina|||0000-0001-5913-1468
  • Ciullo, Valentina|||0000-0002-4095-7806
  • Cook, Edwin H.|||0000-0002-5848-5114
  • Crosby, Jesse
  • Cullen, Bernadette A.|||0000-0003-1762-092X
  • De Schipper, Elles J.|||0000-0001-9494-451X
  • Delorme, Richard|||0000-0002-5614-3663
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Elias, Jason A.
  • Estivill, Xavier|||0000-0002-0723-2256
  • Falkenstein, Martha J.|||0000-0001-5074-3409
  • Fundin, Bengt T.|||0000-0002-6037-7331
  • Garner, Lauryn
  • Gironda, Christina
  • Goes, Fernando S.|||0000-0001-6262-8264
  • Grados, Marco A.|||0000-0002-0178-1764
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Wei|||0000-0002-4322-3699
  • Haavik, Jan|||0000-0001-7865-2808
  • Hagen, Kristen|||0000-0002-4286-1277
  • Harrington, Kelly|||0000-0001-9668-183X
  • Havdahl, Alexandra|||0000-0002-9268-0423
  • Höffler, Kira D.|||0000-0002-0837-1469
  • Hounie, Ana G.|||0000-0002-5026-2880
  • Hucks, Donald|||0000-0002-2700-5798
  • Hultman, Christina|||0000-0002-0327-2410
  • Janecka, Magdalena|||0000-0001-7406-0776
  • Jenike, Eric
  • Karlsson, Elinor K.|||0000-0002-4343-3776
  • Kelley, Kara
  • Klawohn, Julia|||0000-0002-9436-6948
  • Krasnow, Janice E.|||0000-0003-0316-6279
  • Krebs, Kristi|||0000-0003-0494-2751
  • Lange, Christoph|||0000-0002-9691-4741
  • Lanzagorta, Nuria|||0000-0001-6769-6813
  • Levey, Daniel|||0000-0001-8431-9569
  • Lindblad-Toh, Kerstin|||0000-0001-8338-0253
  • Macciardi, Fabio|||0000-0003-0537-4266
  • Maher, Brion|||0000-0001-9809-0064
  • Mathes, Brittany
  • McArthur, Evonne|||0000-0003-4566-4321
  • McGregor, Nathaniel|||0000-0001-7195-4993
  • McLaughlin, Nicole C.|||0000-0002-4016-2747
  • Meier, Sandra|||0000-0002-3287-5894
  • Miguel, Euripedes C.|||0000-0002-9393-3103
  • Mulhern, Maureen|||0000-0001-8642-4741
  • Nestadt, Paul S.
  • Nurmi, Erika L.|||0000-0003-4893-8957
  • O'Connell, Kevin S.|||0000-0002-6865-8795
  • Osiecki, Lisa|||0000-0002-9408-8722
  • Ousdal, Olga Therese|||0000-0002-0728-3141
  • Palviainen, Teemu|||0000-0002-7847-8384
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Piras, Federica|||0000-0002-9546-7038
  • Potluri, Sriramya|||0000-0003-3877-0038
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Rauch, Scott|||0000-0001-7699-6754
  • Reichenberg, Abraham|||0000-0003-2729-8575
  • Riddle, Mark A.|||0000-0001-8764-2134
  • Ripke, Stephan|||0000-0003-3622-835X
  • Rosário, Maria C.|||0000-0002-8577-3306
  • Sampaio, Aline S.|||0000-0001-5568-6167
  • Schiele, Miriam A.|||0000-0003-2613-6515
  • Skogholt, Anne Heidi|||0000-0001-7466-0405
  • Sloofman, Laura G Sloofman G.|||0000-0001-7628-4378
  • Smit, Jan
  • Soler Artigas, María|||0000-0002-3213-1107
  • Thomas, Laurent|||0000-0003-0548-2486
  • Tifft, Eric|||0000-0002-7480-0276
  • Vallada, Homero|||0000-0001-5123-8295
  • van Kirk, Nathanial|||0000-0002-1975-4238
  • Veenstra-VanderWeele, Jeremy|||0000-0002-6349-1076
  • Vulink, Nienke N.|||0000-0001-8991-9627
  • Walker, Christopher P.|||0000-0002-6069-0184
  • Wang, Ying
  • Wendland, Jens|||0000-0001-5106-5013
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Yao, Yin|||0000-0001-7487-4294
  • Zhou, Hang|||0000-0002-7694-6391
  • Agrawal, Arpana|||0000-0002-0313-793X
  • Alonso, Pino|||0000-0002-5779-9111
  • Berberich, Götz|||0000-0001-8300-9294
  • Bucholz, Kathleen K.|||0000-0003-3794-0736
  • Bulik, Cynthia M.|||0000-0001-7772-3264
  • Cath, Danielle|||0000-0001-9539-4118
  • Denys, Damiaan|||0000-0002-3191-3844
  • Eapen, Valsamma|||0000-0001-6296-8306
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Falkai, Peter|||0000-0003-2873-8667
  • Fernandez, Thomas V.|||0000-0003-0830-022X
  • Fyer, Abby J.|||0000-0002-0944-2505
  • Geller, Dan A.|||0000-0001-8692-4156
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Greenberg, Benjamin D.|||0000-0002-5648-0002
  • Hanna, Gregory L.|||0000-0002-0742-6990
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Hougaard, David M.|||0000-0001-5928-3517
  • Kathmann, Norbert|||0000-0002-1348-7060
  • Kennedy, James L.|||0000-0002-8733-3806
  • Lai, Dongbing|||0000-0001-7803-580X
  • Landén, Mikael|||0000-0002-4496-6451
  • Le Hellard, Stéphanie|||0000-0002-8085-051X
  • Leboyer, Marion|||0000-0001-5473-3697
  • Lochner, Christine|||0000-0002-4766-3704
  • McCracken, James T.|||0000-0003-0370-0777
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mortensen, Preben Bo|||0000-0002-5230-9865
  • Neale, Benjamin M.|||0000-0003-1513-6077
  • Nicolini, Humberto|||0000-0003-2494-0067
  • Nordentoft, Merete|||0000-0003-4895-7023
  • Pato, Michele
  • Pato, Carlos|||0000-0002-5858-266X
  • Pauls, David L.|||0000-0002-8107-345X
  • Piacentini, John|||0000-0003-4195-7194
  • Pittenger, Christopher|||0000-0003-2117-9321
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Rasmussen, Steven A.|||0000-0002-8327-0692
  • Richter, Margaret A.|||0000-0001-5450-2936
  • Rosenberg, David R.|||0000-0002-0005-4151
  • Ruhrmann, Stephan|||0000-0002-6022-2364
  • Samuels, Jack F.|||0000-0002-6715-7905
  • Sandin, Sven|||0000-0001-6994-4884
  • Sandor, Paul|||0000-0003-2397-0758
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stein, Dan J.|||0000-0001-7218-7810
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Storch, Eric A.|||0000-0002-7631-3703
  • Stranger, Barbara E.|||0000-0001-9021-7331
  • Turiel, Maurizio|||0000-0002-8793-2112
  • Werge, Thomas|||0000-0003-1829-0766
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Walitza, Susanne|||0000-0002-8161-8683
  • Hveem, Kristian|||0000-0001-8157-9744
  • Hansen, Bjarne K.|||0000-0001-5659-1119
  • Rück, Christian P.|||0000-0002-8742-0168
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Milani, Lili|||0000-0002-5323-3102
  • Mors, Ole|||0000-0002-5660-0393
  • Reichborn-Kjennerud, Ted|||0000-0003-4653-0034
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Kvale, Gerd|||0000-0001-5449-2344
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Domschke, Katharina|||0000-0002-2550-9132
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Wagner, Michael
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Breen, Gerome|||0000-0003-2053-1792
  • Nestadt, Gerald|||0000-0001-9461-5249
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Grice, Dorothy E.|||0000-0002-8833-2549
  • Knowles, James A.|||0000-0002-3307-5741
  • Ask, Helga|||0000-0003-0149-5319
  • Verweij, Karin|||0000-0001-9868-7821
  • Davis, Lea K.|||0000-0001-5143-2282
  • Smit, Dirk J.|||0000-0001-8301-8860
  • Crowley, James J.|||0000-0001-9051-1557
  • Scharf, Jeremiah M.|||0000-0002-4742-5896
  • Stein, Murray B.|||0000-0001-9564-2871
  • Gelernter, Joel|||0000-0002-4067-1859
  • Mathews, Carol A.|||0000-0003-2208-7058
  • Derks, Eske M.|||0000-0002-6292-6883
  • Mattheisen, Manuel|||0000-0002-8442-493X
Obsessive-compulsive disorder (OCD) affects ~1% of children and adults and is partly caused by genetic factors. We conducted a genome-wide association study (GWAS) meta-analysis combining 53,660 OCD cases and 2,044,417 controls and identified 30 independent genome-wide significant loci. Gene-based approaches identified 249 potential effector genes for OCD, with 25 of these classified as the most likely causal candidates, including WDR6, DALRD3 and CTNND1 and multiple genes in the major histocompatibility complex (MHC) region. We estimated that ~11,500 genetic variants explained 90% of OCD genetic heritability. OCD genetic risk was associated with excitatory neurons in the hippocampus and the cortex, along with D and D type dopamine receptor-containing medium spiny neurons. OCD genetic risk was shared with 65 of 112 additional phenotypes, including all the psychiatric disorders we examined. In particular, OCD shared genetic risk with anxiety, depression, anorexia nervosa and Tourette syndrome and was negatively associated with inflammatory bowel diseases, educational attainment and body mass index.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder

  • Richarte Fernández, Vanesa
  • Sanchez Mora, Cristina P
  • Corrales De la Cruz, Montserrat
  • Fadeuilhe Grau, Christian
  • Vilar Ribo, Laura
  • Arribas Garcia, Lorena
  • Garcia Gea, Estela
  • Rosales Ortiz, Silvia Karina
  • Soler Artigas, Maria
  • Ribases Haro, Marta
  • Ramos-Quiroga, Josep Antoni
TDAH; Comunitat científica, TDAH; Comunidad científica, ADHD; Scientific community, Compelling evidence supports alterations in gut microbial diversity, bacterial composition, and/or relative abundance of several bacterial taxa in attention-deficit/hyperactivity disorder (ADHD). However, findings for ADHD are inconsistent among studies, and specific gut microbiome signatures for the disorder remain unknown. Given that previous studies have mainly focused on the pediatric form of the disorder and involved small sample sizes, we conducted the largest study to date to compare the gastrointestinal microbiome composition in 100 medication-naïve adults with ADHD and 100 sex-matched healthy controls. We found evidence that ADHD subjects have differences in the relative abundance of several microbial taxa. At the family level, our data support a lower relative abundance of Gracilibacteraceae and higher levels of Selenomonadaceae and Veillonellaceae in adults with ADHD. In addition, the ADHD group showed higher levels of Dialister and Megamonas and lower abundance of Anaerotaenia and Gracilibacter at the genus level. All four selected genera explained 15% of the variance of ADHD, and this microbial signature achieved an overall sensitivity of 74% and a specificity of 71% for distinguishing between ADHD patients and healthy controls. We also tested whether the selected genera correlate with age, body mass index (BMI), or scores of the ADHD rating scale but found no evidence of correlation between genera relative abundance and any of the selected traits. These results are in line with recent studies supporting gut microbiome alterations in neurodevelopment disorders, but further studies are needed to elucidate the role of the gut microbiota on the ADHD across the lifespan and its contribution to the persistence of the disorder from childhood to adulthood.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Martorell, Lourdes
  • Sanchez-Roige, Sandra
  • Palmer, Abraham
  • Vilar-Ribo, Laura
  • Cabana-Dominguez, Judit
  • Ribases, Marta
  • Soler Artigas, María
  • Ramos-Quiroga, Josep Antoni
Shared genetic architecture; Attention-deficit and hyperactivity disorder; Lifespan, Arquitectura genética compartida; Trastorno por déficit de atención e hiperactividad; Esperanza de vida, Arquitectura genètica compartida; Trastorn per dèficit d'atenció i hiperactivitat; Esperança de vida, There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = −0.36, P = 1.41e−16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e−06; Beta = −0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-00444 and 2017SGR-1461), the Instituto de Salud Carlos III (PI18/01788, P19/01224, PI20/00041, PI21/00612, PI22/00464, FI18/00285 to LVR and CP22/00128 to MSA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD); the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014–2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN) and the ECNP Network ‘ADHD across the Lifespan’ and “la Marató de TV3” (202228-30 and 202228-31). SSR was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526 and T32IR5226), and NIH/NIDA DP1DA054394. AAP was supported by NIH grant P50DA037844 and R01AA029688 and Tobacco-Related Disease Research Program Grant number: 28IR-0070.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

  • hartman, catharina
  • Larsson, Henrik
  • Ribases, Marta
  • Mitjans, Marina
  • Soler Artigas, María
  • Demontis, Ditte
  • Ramos-Quiroga, Josep Antoni
Trastorno por déficit de atención e hiperactividad; Comorbilidad; Genética de trastornos cruzados, Trastorn per dèficit d'atenció i hiperactivitat; Comorbiditat; Genètica de trastorns creuats, Attention-deficit/hyperactivity disorder; Comorbidity; Cross-disorder genetics, Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric disorders and traits. In this review, we summarize and interpret the existing literature on the genetic architecture of these comorbidities based on hypothesis-generating approaches. Quantitative genetic studies indicate that genetic factors play a substantial role in the observed co-occurrence of ADHD with many different disorders and traits. Molecular genetic correlations derived from genome-wide association studies and results of studies based on polygenic risk scores confirm the general pattern but provide effect estimates that are smaller than those from twin studies. The identification of the specific genetic variants and biological pathways underlying co-occurrence using genome-wide approaches is still in its infancy. The first analyses of causal inference using genetic data support causal relationships between ADHD and comorbid disorders, although bidirectional effects identified in some instances point to complex relationships. While several issues in the methodology and inferences from the results are still to be overcome, this review shows that the co-occurrence of ADHD with many psychiatric disorders and traits is genetically interpretable., This research has received funding from the EU’s Horizon 2020 research and innovation program under grant agreements no. 667302 (CoCA), 728018 (Eat2beNICE) and 2020604 (TIMESPAN) and from the ECNP Network ‘ADHD across the Lifespan' (https://www.ecnp.eu/researchinnovation/ECNP-networks/List-ECNP-Networks/). B Cormand has also been supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-1277760B-I100), the Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas (PNSD-2017I050), Fundació La Marató de TV3 (202218-31), Generalitat de Catalunya/AGAUR (2021-SGR-1093), ICREA Academia 2021 and the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 841899 (GRASAD) and 101028810 (ATTENTIVE). M Ribasés was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE), by the Instituto de Salud Carlos III (PI20/00041, CP09/00119 and CPII15/00023), by the Pla estratègic de recerca i innovació en salut (PERIS), Generalitat de Catalunya (METAL-Cat; SLT006/17/287), by the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2017SGR1461) and by Fundació La Marató de TV3 (202228-30, 202228-31). JA Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE). M Mitjans was supported by Horizon 2020 Marie Sklodowska-Curie Individual Fellowship from the European Commission under grant agreement no. 841899 (GRASAD), the MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR” (RYC2021-033573-I), Ministerio de Ciencia e Innovación (PID2022-139740OA-100) and the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2021-SGR-1093). M Soler Artigas was supported by the Instituto de Salud Carlos III (P19/01224, PI22/00464 and CP22/00128) and by the European Regional Development Fund. B Franke and A Reif were also supported by funding from the EU’s Horizon 2020 research and innovation program under grant agreement no. 847879 (PRIME). B Franke also received relevant funding from the Netherlands Organization for Scientific Research (NWO) for the GUTS project (grant 024.005.011). D Demontis is supported by the Novo Nordisk Foundation (NNF20OC0065561 and NNF21SA0072102), the Lundbeck Foundation (R344-2020-1060), the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 965381 (TIMESPAN). AD Børglum was supported by the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003). Research reported in this publication was also supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH124851. The content of the publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any of the other funding organisations mentioned here.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor

  • Winsvold, Bendik Slagsvold
  • Harder, Aster
  • Ran, Caroline
  • Chalmer, Mona Ameri
  • Dalmasso, Maria Carolina
  • Ferkingstad, Egil
  • Gallardo López, Víctor J.
  • Ribases, Marta
  • Soler Artigas, María
  • Pozo-Rosich, Patricia
  • Ramos-Quiroga, Josep Antoni
Genome; Headache; Smoking, Genoma; Cefalea; Tabaquisme, Genoma; Cefalea; Tabaquismo, Objective The objective of this study was to aggregate data for the first genomewide association study meta-analysis of cluster headache, to identify genetic risk variants, and gain biological insights. Methods A total of 4,777 cases (3,348 men and 1,429 women) with clinically diagnosed cluster headache were recruited from 10 European and 1 East Asian cohorts. We first performed an inverse-variance genomewide association meta-analysis of 4,043 cases and 21,729 controls of European ancestry. In a secondary trans-ancestry meta-analysis, we included 734 cases and 9,846 controls of East Asian ancestry. Candidate causal genes were prioritized by 5 complementary methods: expression quantitative trait loci, transcriptome-wide association, fine-mapping of causal gene sets, genetically driven DNA methylation, and effects on protein structure. Gene set and tissue enrichment analyses, genetic correlation, genetic risk score analysis, and Mendelian randomization were part of the downstream analyses. Results The estimated single nucleotide polymorphism (SNP)-based heritability of cluster headache was 14.5%. We identified 9 independent signals in 7 genomewide significant loci in the primary meta-analysis, and one additional locus in the trans-ethnic meta-analysis. Five of the loci were previously known. The 20 genes prioritized as potentially causal for cluster headache showed enrichment to artery and brain tissue. Cluster headache was genetically correlated with cigarette smoking, risk-taking behavior, attention deficit hyperactivity disorder (ADHD), depression, and musculoskeletal pain. Mendelian randomization analysis indicated a causal effect of cigarette smoking intensity on cluster headache. Three of the identified loci were shared with migraine. Interpretation This first genomewide association study meta-analysis gives clues to the biological basis of cluster headache and indicates that smoking is a causal risk factor. ANN NEUROL 2023;94:713–726, This work was funded by the South-Eastern Norway Regional Health Authority (#2020034); the Swedish National Infrastructure for Computing (SNIC) at Uppmax, Uppsala University partially funded by the Swedish Research Council through grant agreement no. 2018-05973; the Wellcome Trust under award 076113, 085475, and 090355; the Instituto de Salud Carlos III (PI18/01788, PI19/01224, and PI20/00041); the European Regional Development Fund (ERDF); the Biomedical Network Research Center on Mental Health (CIBERSAM, Madrid, Spain); the Agència de Gestió d'Ajuts Universitaris i de Recerca-AGAUR, Generalitat de Catalunya (2017SGR1461); the Netherlands Organization for Scientific Research, ie, the Center of Medical System Biology established by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (to A.M.J.M.v.d.M.); the EU-funded FP7 “EUROHEADPAIN” (grant no. 6026337 to A.M.J.M.v.d.M.); The NEO study, which comprised of the Dutch controls, was supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Centre, and by the Leiden University, Research Profile Area “Vascular and Regenerative Medicine”; A.V.E. Harder was sponsored by the Leiden University Fund/Fonds Mr. J.J. van Enter “Pro Universitate”, www.luf.nl (grant W212163-2-64). Part of the genotyping of the German sample was funded by the JPND EADB grant to AR (German Federal Ministry of Education and Research [BMBF] grant: 01ED1619A); the BMBF (grants KND: 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, and 01GI0434; grants KNDD: 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, and 01GI0716; grants Health Service Research Initiative: 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, and 01GY1322G); PainFACT (H2020-2020-848099) to T.E.T; Italian Ministry of Health (RF2009-1549619); The Research Funding Pool at Rigshospitalet to M.A.C.; The Swedish Brain Foundation and the Mellby Gård Foundation (FO2020-0006 and FO2022-0001); Karolinska Institutet Research Funds (2018-01738, 2020-01411, and 2022-01781); The Swedish Research Council (2017-01096); the Region Stockholm (ALF project 20200095); the Ministry of Science and Technology, Taiwan [MOST-108-2314-B-010-022-MY3 and 110-2326-B-A49A-501-MY3].
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder

  • Richarte, Vanesa|||0000-0001-7327-318X
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Arribas, Lorena|||0000-0002-9683-9999
  • García-Estela, Aitana|||0000-0001-8529-544X
  • Rosales, Silvia Karina|||0000-0003-0834-7423
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
Compelling evidence supports alterations in gut microbial diversity, bacterial composition, and/or relative abundance of several bacterial taxa in attention-deficit/hyperactivity disorder (ADHD). However, findings for ADHD are inconsistent among studies, and specific gut microbiome signatures for the disorder remain unknown. Given that previous studies have mainly focused on the pediatric form of the disorder and involved small sample sizes, we conducted the largest study to date to compare the gastrointestinal microbiome composition in 100 medication-naïve adults with ADHD and 100 sex-matched healthy controls. We found evidence that ADHD subjects have differences in the relative abundance of several microbial taxa. At the family level, our data support a lower relative abundance of Gracilibacteraceae and higher levels of Selenomonadaceae and Veillonellaceae in adults with ADHD. In addition, the ADHD group showed higher levels of Dialister and Megamonas and lower abundance of Anaerotaenia and Gracilibacter at the genus level. All four selected genera explained 15% of the variance of ADHD, and this microbial signature achieved an overall sensitivity of 74% and a specificity of 71% for distinguishing between ADHD patients and healthy controls. We also tested whether the selected genera correlate with age, body mass index (BMI), or scores of the ADHD rating scale but found no evidence of correlation between genera relative abundance and any of the selected traits. These results are in line with recent studies supporting gut microbiome alterations in neurodevelopment disorders, but further studies are needed to elucidate the role of the gut microbiota on the ADHD across the lifespan and its contribution to the persistence of the disorder from childhood to adulthood.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD)

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Soler Artigas, María|||0000-0002-3213-1107
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Llonga, Natalia|||0000-0003-4325-6201
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder that results from the interaction of both genetic and environmental risk factors. Genome-wide association studies have started to identify multiple genetic risk loci associated with ADHD, however, the exact causal genes and biological mechanisms remain largely unknown. We performed a multi-step analysis to identify and characterize modules of co-expressed genes associated with ADHD using data from peripheral blood mononuclear cells of 270 ADHD cases and 279 controls. We identified seven ADHD-associated modules of co-expressed genes, some of them enriched in both genetic and epigenetic signatures for ADHD and in biological pathways relevant for psychiatric disorders, such as the regulation of gene expression, epigenetics and immune system. In addition, for some of the modules, we found evidence of potential regulatory mechanisms, including microRNAs and common genetic variants. In conclusion, our results point to promising genes and pathways for ADHD, supporting the use of peripheral blood to assess gene expression signatures in psychiatric disorders. Furthermore, they highlight that the combination of multi-omics signals provides deeper and broader insights into the biological mechanisms underlying ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mendelian randomization analysis for attention deficit/hyperactivity disorder, studying a broad range of exposures and outcomes

  • Soler Artigas, María|||0000-0002-3213-1107
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Rovira, Paula|||0000-0003-2177-8412
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder caused by a combination of genetic and environmental factors and is often thought as an entry point into a negative life trajectory, including risk for comorbid disorders, poor educational achievement or low income. In the present study, we aimed to clarify the causal relationship between ADHD and a comprehensive range of related traits. We used genome-wide association study (GWAS) summary statistics for ADHD (n = 53 293) and 124 traits related to anthropometry, cognitive function and intelligence, early life exposures, education and employment, lifestyle and environment, longevity, neurological, and psychiatric and mental health or personality and psychosocial factors available in the MR-Base database (16 067 ≤ n ≤766 345). To investigate their causal relationship with ADHD, we used two-sample Mendelian randomization (MR) with a range of sensitivity analyses, and validated MR findings using causal analysis using summary effect estimates (CAUSE), aiming to avoid potential false-positive results. Our findings strengthen previous evidence of a causal effect of ADHD liability on smoking and major depression, and are consistent with a causal effect on odds of decreased average total household income [odds ratio (OR) = 0.966, 95% credible interval (CrI) = (0.954, 0.979)] and increased lifetime number of sexual partners [OR = 1.023, 95% CrI = (1.013, 1.033)]. We also found evidence for a causal effect on ADHD for liability of arm predicted mass and weight [OR = 1.452, 95% CrI = (1.307, 1.614) and OR = 1.430, 95% CrI = (1.326, 1.539), respectively] and time spent watching television [OR = 1.862, 95% CrI = (1.545, 2.246)], and evidence for a bidirectional effect for age of first sexual intercourse [beta = -0.058, 95% CrI = (-0.072, -0.044) and OR = 0.413, 95% CrI = (0.372, 0.457), respectively], odds of decreased age completed full-time education [OR = 0.972, 95% CrI = (0.962, 0.981) and OR = 0.435, 95% CrI = (0.356, 0.533), respectively] and years of schooling [beta = -0.036, 95% CrI = (-0.048, -0.024) and OR = 0.458, 95% CrI = (0.411, 0.511), respectively]. Our results may contribute to explain part of the widespread co-occurring traits and comorbid disorders across the lifespan of individuals with ADHD and may open new opportunities for developing preventive strategies for ADHD and for negative ADHD trajectories.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Martorell, Lourdes|||0000-0003-4999-2197
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Sánchez Roige, Sandra|||0000-0001-6137-5699
  • Palmer, Abraham A.
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Muntané, Gerard|||0000-0003-1541-8365
  • Soler Artigas, María|||0000-0002-3213-1107
There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = -0.36, P = 1.41e-16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e-06; Beta = -0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo preliminar (WorkingPaper)

Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci

  • Strom, Nora I.|||0000-0002-5261-8852
  • Gerring, Zachary F.|||0000-0002-2445-1266
  • Galimberti, Marco|||0000-0001-6052-156X
  • Yu, Dongmei|||0000-0001-7901-4365
  • Halvorsen, Matthew W.|||0000-0002-6707-2418
  • Abdellaoui, Abdel|||0000-0003-1088-6784
  • Rodriguez-Fontenla, Cristina|||0000-0002-9829-6393
  • Sealock, Julia M.|||0000-0002-9346-3498
  • Bigdeli, Tim B.|||0000-0003-2215-5946
  • Coleman, Jonathan R. I.|||0000-0002-6759-0944
  • Mahjani, Behrang|||0000-0001-6087-9537
  • Thorp, Jackson G.|||0000-0002-9461-6417
  • Bey, Katharina|||0000-0001-6392-4997
  • Burton, Christie L.|||0000-0002-8955-6528
  • Luykx, Jurjen J.|||0000-0002-6439-2774
  • Zai, Gwyneth|||0000-0002-0894-6867
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Andre, Christine
  • Askland, Kathleen D.|||0000-0003-1467-8923
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Barlassina, Cristina|||0000-0001-7407-2697
  • Nissen, Judith Becker|||0000-0003-4063-6866
  • Bienvenu, O. Joseph|||0000-0002-8466-102X
  • Black, Donald|||0000-0001-8038-1971
  • Bloch, Michael H.|||0000-0003-0352-4080
  • Boberg, Julia|||0000-0003-3399-2838
  • Børte, Sigrid|||0000-0001-9540-3256
  • Bosch, Rosa|||0000-0002-7596-183X
  • Breen, Michael
  • Brennan, Brian P.|||0000-0001-5468-6552
  • Brentani, Helena|||0000-0001-5192-4682
  • Buxbaum, Joseph D.|||0000-0001-8898-8313
  • Bybjerg-Grauholm, Jonas|||0000-0003-1705-4008
  • Byrne, Enda M.|||0000-0002-9491-7797
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Camarena, Beatriz
  • Camarena, Adrian|||0000-0001-8512-0607
  • Cappi, Carolina|||0000-0001-6661-3756
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Cavallini, Maria Cristina|||0000-0001-5913-1468
  • Ciullo, Valentina|||0000-0002-4095-7806
  • Cook, Edwin H.|||0000-0002-5848-5114
  • Crosby, Jesse
  • Cullen, Bernadette A.|||0000-0003-1762-092X
  • De Schipper, Elles J.|||0000-0001-9494-451X
  • Delorme, Richard|||0000-0002-5614-3663
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Elias, Jason A.
  • Estivill, Xavier|||0000-0002-0723-2256
  • Falkenstein, Martha J.|||0000-0001-5074-3409
  • Fundin, Bengt T.|||0000-0002-6037-7331
  • Garner, Lauryn
  • German, Chris
  • Gironda, Christina
  • Goes, Fernando S.|||0000-0001-6262-8264
  • Grados, Marco A.|||0000-0002-0178-1764
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Wei|||0000-0002-4322-3699
  • Haavik, Jan|||0000-0001-7865-2808
  • Hagen, Kristen|||0000-0002-4286-1277
  • Harrington, Kelly|||0000-0001-9668-183X
  • Havdahl, Alexandra|||0000-0002-9268-0423
  • Höffler, Kira D.|||0000-0002-0837-1469
  • Hounie, Ana G.|||0000-0002-5026-2880
  • Hucks, Donald|||0000-0002-2700-5798
  • Hultman, Christina|||0000-0002-0327-2410
  • Janecka, Magdalena|||0000-0001-7406-0776
  • Jenike, Eric
  • Karlsson, Elinor K.|||0000-0002-4343-3776
  • Kelley, Kara
  • Klawohn, Julia|||0000-0002-9436-6948
  • Krasnow, Janice E.|||0000-0003-0316-6279
  • Krebs, Kristi|||0000-0003-0494-2751
  • Lange, Christoph|||0000-0002-9691-4741
  • Lanzagorta, Nuria|||0000-0001-6769-6813
  • Levey, Daniel|||0000-0001-8431-9569
  • Lindblad-Toh, Kerstin|||0000-0001-8338-0253
  • Macciardi, Fabio|||0000-0003-0537-4266
  • Maher, Brion|||0000-0001-9809-0064
  • Mathes, Brittany
  • McArthur, Evonne|||0000-0003-4566-4321
  • McGregor, Nathaniel|||0000-0001-7195-4993
  • McLaughlin, Nicole C.|||0000-0002-4016-2747
  • Meier, Sandra|||0000-0002-3287-5894
  • Miguel, Euripedes C.|||0000-0002-9393-3103
  • Mulhern, Maureen|||0000-0001-8642-4741
  • Nestadt, Paul S.
  • Nurmi, Erika L.|||0000-0003-4893-8957
  • O'Connell, Kevin S.|||0000-0002-6865-8795
  • Osiecki, Lisa|||0000-0002-9408-8722
  • Ousdal, Olga Therese|||0000-0002-0728-3141
  • Palviainen, Teemu|||0000-0002-7847-8384
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Piras, Federica|||0000-0002-9546-7038
  • Potluri, Sriramya|||0000-0003-3877-0038
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Rauch, Scott|||0000-0001-7699-6754
  • Reichenberg, Abraham|||0000-0003-2729-8575
  • Riddle, Mark A.|||0000-0001-8764-2134
  • Ripke, Stephan|||0000-0003-3622-835X
  • Rosário, Maria C.|||0000-0002-8577-3306
  • Sampaio, Aline S.|||0000-0001-5568-6167
  • Schiele, Miriam A.|||0000-0003-2613-6515
  • Skogholt, Anne Heidi|||0000-0001-7466-0405
  • Sloofman, Laura G Sloofman G.|||0000-0001-7628-4378
  • Smit, Jan
  • Soler Artigas, María|||0000-0002-3213-1107
  • Thomas, Laurent|||0000-0003-0548-2486
  • Tifft, Eric|||0000-0002-7480-0276
  • Vallada, Homero|||0000-0001-5123-8295
  • van Kirk, Nathanial|||0000-0002-1975-4238
  • Veenstra-VanderWeele, Jeremy|||0000-0002-6349-1076
  • Vulink, Nienke N.|||0000-0001-8991-9627
  • Walker, Christopher P.|||0000-0002-6069-0184
  • Wang, Ying
  • Wendland, Jens|||0000-0001-5106-5013
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Yao, Yin|||0000-0001-7487-4294
  • Zhou, Hang|||0000-0002-7694-6391
  • Agrawal, Arpana|||0000-0002-0313-793X
  • Alonso, Pino|||0000-0002-5779-9111
  • Berberich, Götz|||0000-0001-8300-9294
  • Bucholz, Kathleen K.|||0000-0003-3794-0736
  • Bulik, Cynthia M.|||0000-0001-7772-3264
  • Cath, Danielle|||0000-0001-9539-4118
  • Denys, Damiaan|||0000-0002-3191-3844
  • Eapen, Valsamma|||0000-0001-6296-8306
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Falkai, Peter|||0000-0003-2873-8667
  • Fernandez, Thomas V.|||0000-0003-0830-022X
  • Fyer, Abby J.|||0000-0002-0944-2505
  • Gaziano, J M.|||0000-0002-5384-9767
  • Geller, Dan A.|||0000-0001-8692-4156
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Greenberg, Benjamin D.|||0000-0002-5648-0002
  • Hanna, Gregory L.|||0000-0002-0742-6990
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Hougaard, David M.|||0000-0001-5928-3517
  • Kathmann, Norbert|||0000-0002-1348-7060
  • Kennedy, James L.|||0000-0002-8733-3806
  • Lai, Dongbing|||0000-0001-7803-580X
  • Landén, Mikael|||0000-0002-4496-6451
  • Le Hellard, Stéphanie|||0000-0002-8085-051X
  • Leboyer, Marion|||0000-0001-5473-3697
  • Lochner, Christine|||0000-0002-4766-3704
  • McCracken, James T.|||0000-0003-0370-0777
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mortensen, Preben B.|||0000-0002-4782-1450
  • Neale, Benjamin M.|||0000-0003-1513-6077
  • Nicolini, Humberto|||0000-0003-2494-0067
  • Nordentoft, Merete|||0000-0003-4895-7023
  • Pato, Michele
  • Pato, Carlos|||0000-0002-5858-266X
  • Pauls, David L.|||0000-0002-8107-345X
  • Piacentini, John|||0000-0003-4195-7194
  • Pittenger, Christopher|||0000-0003-2117-9321
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Rasmussen, Steven A.|||0000-0002-8327-0692
  • Richter, Margaret A.|||0000-0001-5450-2936
  • Rosenberg, David R.|||0000-0002-0005-4151
  • Ruhrmann, Stephan|||0000-0002-6022-2364
  • Samuels, Jack F.|||0000-0002-6715-7905
  • Sandin, Sven|||0000-0001-6994-4884
  • Sandor, Paul|||0000-0003-2397-0758
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stein, Dan J.|||0000-0001-7218-7810
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Storch, Eric A.|||0000-0002-7631-3703
  • Stranger, Barbara E.|||0000-0001-9021-7331
  • Turiel, Maurizio|||0000-0002-8793-2112
  • Werge, Thomas|||0000-0003-1829-0766
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Walitza, Susanne|||0000-0002-8161-8683
  • Hveem, Kristian|||0000-0001-8157-9744
  • Hansen, Bjarne K.|||0000-0001-5659-1119
  • Rück, Christian P.|||0000-0002-8742-0168
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Milani, Lili|||0000-0002-5323-3102
  • Mors, Ole|||0000-0002-5660-0393
  • Reichborn-Kjennerud, Ted|||0000-0003-4653-0034
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Kvale, Gerd|||0000-0001-5449-2344
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Domschke, Katharina|||0000-0002-2550-9132
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Wagner, Michael
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Breen, Gerome|||0000-0003-2053-1792
  • Nestadt, Gerald|||0000-0001-9461-5249
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Grice, Dorothy E.|||0000-0002-8833-2549
  • Knowles, James A.|||0000-0002-3307-5741
  • Ask, Helga|||0000-0003-0149-5319
  • Verweij, Karin|||0000-0001-9868-7821
  • Davis, Lea K.|||0000-0001-5143-2282
  • Smit, Dirk J.|||0000-0001-8301-8860
  • Crowley, James J.|||0000-0001-9051-1557
  • Scharf, Jeremiah M.|||0000-0002-4742-5896
  • Stein, Murray B.|||0000-0001-9564-2871
  • Gelernter, Joel|||0000-0002-4067-1859
  • Mathews, Carol A.|||0000-0003-2208-7058
  • Derks, Eske M.|||0000-0002-6292-6883
  • Mattheisen, Manuel|||0000-0002-8442-493X
Obsessive-compulsive disorder (OCD) affects ~1% of the population and exhibits a high SNP-heritability, yet previous genome-wide association studies (GWAS) have provided limited information on the genetic etiology and underlying biological mechanisms of the disorder. We conducted a GWAS meta-analysis combining 53,660 OCD cases and 2,044,417 controls from 28 European-ancestry cohorts revealing 30 independent genome-wide significant SNPs and a SNP-based heritability of 6.7%. Separate GWAS for clinical, biobank, comorbid, and self-report sub-groups found no evidence of sample ascertainment impacting our results. Functional and positional QTL gene-based approaches identified 249 significant candidate risk genes for OCD, of which 25 were identified as putatively causal, highlighting WDR6, DALRD3, CTNND1 and genes in the MHC region. Tissue and single-cell enrichment analyses highlighted hippocampal and cortical excitatory neurons, along with D1- and D2-type dopamine receptor-containing medium spiny neurons, as playing a role in OCD risk. OCD displayed significant genetic correlations with 65 out of 112 examined phenotypes. Notably, it showed positive genetic correlations with all included psychiatric phenotypes, in particular anxiety, depression, anorexia nervosa, and Tourette syndrome, and negative correlations with a subset of the included autoimmune disorders, educational attainment, and body mass index.. This study marks a significant step toward unraveling its genetic landscape and advances understanding of OCD genetics, providing a foundation for future interventions to address this debilitating disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Mitjans, M.
  • Hartman, CA.
  • Artigas, M. Soler
  • Demontis, Ditte|||0000-0001-9124-2766
  • Larsson, Henrik
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Kuntsi, J.
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Børglum, AD.
  • Reif, Andreas|||0000-0002-0992-634X
  • Franke, Barbara|||0000-0003-4375-6572
  • Cormand, Bru|||0000-0001-5318-4382
Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric disorders and traits. In this review, we summarize and interpret the existing literature on the genetic architecture of these comorbidities based on hypothesis-generating approaches. Quantitative genetic studies indicate that genetic factors play a substantial role in the observed co-occurrence of ADHD with many different disorders and traits. Molecular genetic correlations derived from genome-wide association studies and results of studies based on polygenic risk scores confirm the general pattern but provide effect estimates that are smaller than those from twin studies. The identification of the specific genetic variants and biological pathways underlying co-occurrence using genome-wide approaches is still in its infancy. The first analyses of causal inference using genetic data support causal relationships between ADHD and comorbid disorders, although bidirectional effects identified in some instances point to complex relationships. While several issues in the methodology and inferences from the results are still to be overcome, this review shows that the co-occurrence of ADHD with many psychiatric disorders and traits is genetically interpretable.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Demontis, Ditte|||0000-0001-9124-2766
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder

  • Richarte Fernández, Vanesa
  • Sanchez Mora, Cristina P
  • Corrales De la Cruz, Montserrat
  • Fadeuilhe Grau, Christian
  • Vilar Ribo, Laura
  • Arribas Garcia, Lorena
  • Garcia Gea, Estela
  • Rosales Ortiz, Silvia Karina
  • Soler Artigas, Maria
  • Ribases Haro, Marta
  • Ramos-Quiroga, Josep Antoni
TDAH; Comunitat científica, TDAH; Comunidad científica, ADHD; Scientific community, Compelling evidence supports alterations in gut microbial diversity, bacterial composition, and/or relative abundance of several bacterial taxa in attention-deficit/hyperactivity disorder (ADHD). However, findings for ADHD are inconsistent among studies, and specific gut microbiome signatures for the disorder remain unknown. Given that previous studies have mainly focused on the pediatric form of the disorder and involved small sample sizes, we conducted the largest study to date to compare the gastrointestinal microbiome composition in 100 medication-naïve adults with ADHD and 100 sex-matched healthy controls. We found evidence that ADHD subjects have differences in the relative abundance of several microbial taxa. At the family level, our data support a lower relative abundance of Gracilibacteraceae and higher levels of Selenomonadaceae and Veillonellaceae in adults with ADHD. In addition, the ADHD group showed higher levels of Dialister and Megamonas and lower abundance of Anaerotaenia and Gracilibacter at the genus level. All four selected genera explained 15% of the variance of ADHD, and this microbial signature achieved an overall sensitivity of 74% and a specificity of 71% for distinguishing between ADHD patients and healthy controls. We also tested whether the selected genera correlate with age, body mass index (BMI), or scores of the ADHD rating scale but found no evidence of correlation between genera relative abundance and any of the selected traits. These results are in line with recent studies supporting gut microbiome alterations in neurodevelopment disorders, but further studies are needed to elucidate the role of the gut microbiota on the ADHD across the lifespan and its contribution to the persistence of the disorder from childhood to adulthood.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor

  • Winsvold, Bendik Slagsvold
  • Harder, Aster
  • Ran, Caroline
  • Chalmer, Mona Ameri
  • Dalmasso, Maria Carolina
  • Ferkingstad, Egil
  • Gallardo López, Víctor J.
  • Ribases, Marta
  • Soler Artigas, María
  • Pozo-Rosich, Patricia
  • Ramos-Quiroga, Josep Antoni
Genome; Headache; Smoking, Genoma; Cefalea; Tabaquisme, Genoma; Cefalea; Tabaquismo, Objective The objective of this study was to aggregate data for the first genomewide association study meta-analysis of cluster headache, to identify genetic risk variants, and gain biological insights. Methods A total of 4,777 cases (3,348 men and 1,429 women) with clinically diagnosed cluster headache were recruited from 10 European and 1 East Asian cohorts. We first performed an inverse-variance genomewide association meta-analysis of 4,043 cases and 21,729 controls of European ancestry. In a secondary trans-ancestry meta-analysis, we included 734 cases and 9,846 controls of East Asian ancestry. Candidate causal genes were prioritized by 5 complementary methods: expression quantitative trait loci, transcriptome-wide association, fine-mapping of causal gene sets, genetically driven DNA methylation, and effects on protein structure. Gene set and tissue enrichment analyses, genetic correlation, genetic risk score analysis, and Mendelian randomization were part of the downstream analyses. Results The estimated single nucleotide polymorphism (SNP)-based heritability of cluster headache was 14.5%. We identified 9 independent signals in 7 genomewide significant loci in the primary meta-analysis, and one additional locus in the trans-ethnic meta-analysis. Five of the loci were previously known. The 20 genes prioritized as potentially causal for cluster headache showed enrichment to artery and brain tissue. Cluster headache was genetically correlated with cigarette smoking, risk-taking behavior, attention deficit hyperactivity disorder (ADHD), depression, and musculoskeletal pain. Mendelian randomization analysis indicated a causal effect of cigarette smoking intensity on cluster headache. Three of the identified loci were shared with migraine. Interpretation This first genomewide association study meta-analysis gives clues to the biological basis of cluster headache and indicates that smoking is a causal risk factor. ANN NEUROL 2023;94:713–726, This work was funded by the South-Eastern Norway Regional Health Authority (#2020034); the Swedish National Infrastructure for Computing (SNIC) at Uppmax, Uppsala University partially funded by the Swedish Research Council through grant agreement no. 2018-05973; the Wellcome Trust under award 076113, 085475, and 090355; the Instituto de Salud Carlos III (PI18/01788, PI19/01224, and PI20/00041); the European Regional Development Fund (ERDF); the Biomedical Network Research Center on Mental Health (CIBERSAM, Madrid, Spain); the Agència de Gestió d'Ajuts Universitaris i de Recerca-AGAUR, Generalitat de Catalunya (2017SGR1461); the Netherlands Organization for Scientific Research, ie, the Center of Medical System Biology established by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (to A.M.J.M.v.d.M.); the EU-funded FP7 “EUROHEADPAIN” (grant no. 6026337 to A.M.J.M.v.d.M.); The NEO study, which comprised of the Dutch controls, was supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Centre, and by the Leiden University, Research Profile Area “Vascular and Regenerative Medicine”; A.V.E. Harder was sponsored by the Leiden University Fund/Fonds Mr. J.J. van Enter “Pro Universitate”, www.luf.nl (grant W212163-2-64). Part of the genotyping of the German sample was funded by the JPND EADB grant to AR (German Federal Ministry of Education and Research [BMBF] grant: 01ED1619A); the BMBF (grants KND: 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, and 01GI0434; grants KNDD: 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, and 01GI0716; grants Health Service Research Initiative: 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, and 01GY1322G); PainFACT (H2020-2020-848099) to T.E.T; Italian Ministry of Health (RF2009-1549619); The Research Funding Pool at Rigshospitalet to M.A.C.; The Swedish Brain Foundation and the Mellby Gård Foundation (FO2020-0006 and FO2022-0001); Karolinska Institutet Research Funds (2018-01738, 2020-01411, and 2022-01781); The Swedish Research Council (2017-01096); the Region Stockholm (ALF project 20200095); the Ministry of Science and Technology, Taiwan [MOST-108-2314-B-010-022-MY3 and 110-2326-B-A49A-501-MY3].
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

  • hartman, catharina
  • Larsson, Henrik
  • Ribases, Marta
  • Mitjans, Marina
  • Soler Artigas, María
  • Demontis, Ditte
  • Ramos-Quiroga, Josep Antoni
Trastorno por déficit de atención e hiperactividad; Comorbilidad; Genética de trastornos cruzados, Trastorn per dèficit d'atenció i hiperactivitat; Comorbiditat; Genètica de trastorns creuats, Attention-deficit/hyperactivity disorder; Comorbidity; Cross-disorder genetics, Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric disorders and traits. In this review, we summarize and interpret the existing literature on the genetic architecture of these comorbidities based on hypothesis-generating approaches. Quantitative genetic studies indicate that genetic factors play a substantial role in the observed co-occurrence of ADHD with many different disorders and traits. Molecular genetic correlations derived from genome-wide association studies and results of studies based on polygenic risk scores confirm the general pattern but provide effect estimates that are smaller than those from twin studies. The identification of the specific genetic variants and biological pathways underlying co-occurrence using genome-wide approaches is still in its infancy. The first analyses of causal inference using genetic data support causal relationships between ADHD and comorbid disorders, although bidirectional effects identified in some instances point to complex relationships. While several issues in the methodology and inferences from the results are still to be overcome, this review shows that the co-occurrence of ADHD with many psychiatric disorders and traits is genetically interpretable., This research has received funding from the EU’s Horizon 2020 research and innovation program under grant agreements no. 667302 (CoCA), 728018 (Eat2beNICE) and 2020604 (TIMESPAN) and from the ECNP Network ‘ADHD across the Lifespan' (https://www.ecnp.eu/researchinnovation/ECNP-networks/List-ECNP-Networks/). B Cormand has also been supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-1277760B-I100), the Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas (PNSD-2017I050), Fundació La Marató de TV3 (202218-31), Generalitat de Catalunya/AGAUR (2021-SGR-1093), ICREA Academia 2021 and the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 841899 (GRASAD) and 101028810 (ATTENTIVE). M Ribasés was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE), by the Instituto de Salud Carlos III (PI20/00041, CP09/00119 and CPII15/00023), by the Pla estratègic de recerca i innovació en salut (PERIS), Generalitat de Catalunya (METAL-Cat; SLT006/17/287), by the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2017SGR1461) and by Fundació La Marató de TV3 (202228-30, 202228-31). JA Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE). M Mitjans was supported by Horizon 2020 Marie Sklodowska-Curie Individual Fellowship from the European Commission under grant agreement no. 841899 (GRASAD), the MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR” (RYC2021-033573-I), Ministerio de Ciencia e Innovación (PID2022-139740OA-100) and the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2021-SGR-1093). M Soler Artigas was supported by the Instituto de Salud Carlos III (P19/01224, PI22/00464 and CP22/00128) and by the European Regional Development Fund. B Franke and A Reif were also supported by funding from the EU’s Horizon 2020 research and innovation program under grant agreement no. 847879 (PRIME). B Franke also received relevant funding from the Netherlands Organization for Scientific Research (NWO) for the GUTS project (grant 024.005.011). D Demontis is supported by the Novo Nordisk Foundation (NNF20OC0065561 and NNF21SA0072102), the Lundbeck Foundation (R344-2020-1060), the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 965381 (TIMESPAN). AD Børglum was supported by the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003). Research reported in this publication was also supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH124851. The content of the publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any of the other funding organisations mentioned here.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Martorell, Lourdes
  • Sanchez-Roige, Sandra
  • Palmer, Abraham
  • Vilar-Ribo, Laura
  • Cabana-Dominguez, Judit
  • Ribases, Marta
  • Soler Artigas, María
  • Ramos-Quiroga, Josep Antoni
Shared genetic architecture; Attention-deficit and hyperactivity disorder; Lifespan, Arquitectura genética compartida; Trastorno por déficit de atención e hiperactividad; Esperanza de vida, Arquitectura genètica compartida; Trastorn per dèficit d'atenció i hiperactivitat; Esperança de vida, There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = −0.36, P = 1.41e−16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e−06; Beta = −0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-00444 and 2017SGR-1461), the Instituto de Salud Carlos III (PI18/01788, P19/01224, PI20/00041, PI21/00612, PI22/00464, FI18/00285 to LVR and CP22/00128 to MSA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD); the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014–2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN) and the ECNP Network ‘ADHD across the Lifespan’ and “la Marató de TV3” (202228-30 and 202228-31). SSR was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526 and T32IR5226), and NIH/NIDA DP1DA054394. AAP was supported by NIH grant P50DA037844 and R01AA029688 and Tobacco-Related Disease Research Program Grant number: 28IR-0070.